Table 1.

Effect on first and total number of major coronary events

	First events			Total events
Follow-up period	Anacetrapib	Placebo	Events avoided per 1000 patients	Anacetrapib	Placebo	Events avoided per 1000 patients
In-trial	1643	1805	10.6	2142	2408	17.5
Post-trial	503	614	10.1	719	872	12.0
Combined	2146	2419	17.9	2861	3280	27.5